Increased fibroblast growth factor-21 in chronic kidney disease is a trade-off between survival benefit and blood pressure dysregulation
| Image |  |
|---|---|
| Description | scientific article published on 17 December 2019 |
| Author/s |
author: Kunihiro Yamagata Ruri Kaneda |
| Publication date | December 17, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |